NO20031997L - CRF-reseptor-antagonist og metoder relatert dertil - Google Patents
CRF-reseptor-antagonist og metoder relatert dertilInfo
- Publication number
- NO20031997L NO20031997L NO20031997A NO20031997A NO20031997L NO 20031997 L NO20031997 L NO 20031997L NO 20031997 A NO20031997 A NO 20031997A NO 20031997 A NO20031997 A NO 20031997A NO 20031997 L NO20031997 L NO 20031997L
- Authority
- NO
- Norway
- Prior art keywords
- receptor antagonist
- methods related
- crf receptor
- crf
- methods
- Prior art date
Links
- 239000002769 corticotropin releasing factor antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24582100P | 2000-11-03 | 2000-11-03 | |
| PCT/US2001/047919 WO2002040480A2 (en) | 2000-11-03 | 2001-11-02 | Crf receptor antagonists and methods relating thereto |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031997L true NO20031997L (no) | 2003-05-02 |
| NO20031997D0 NO20031997D0 (no) | 2003-05-02 |
Family
ID=22928212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031997A NO20031997D0 (no) | 2000-11-03 | 2003-05-02 | CRF-reseptor-antagonist og metoder relatert dertil |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US6747034B2 (no) |
| EP (1) | EP1341793B1 (no) |
| JP (1) | JP2004529075A (no) |
| KR (1) | KR20030060927A (no) |
| AU (2) | AU2002239589B2 (no) |
| CA (1) | CA2427656A1 (no) |
| DE (1) | DE60126134T2 (no) |
| ES (1) | ES2279835T3 (no) |
| MX (1) | MXPA03003714A (no) |
| NO (1) | NO20031997D0 (no) |
| WO (1) | WO2002040480A2 (no) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7273871B2 (en) * | 2001-07-17 | 2007-09-25 | Sb Pharmco Puerto Rico Inc. | Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists |
| RS20050532A (sr) | 2003-01-14 | 2007-12-31 | Arena Pharmaceuticals Inc., | Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija |
| DE602004009097T2 (de) * | 2003-06-10 | 2008-06-19 | F. Hoffmann-La Roche Ag | 1.3.4-triaza-phenalen- und 1,3,4,6-tetraazaphenalen-derivate |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| KR20060056944A (ko) | 2003-07-14 | 2006-05-25 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서 융합된 아릴 및 헤테로아릴 유도체 및이에 관련된 장애의 예방 또는 치료 |
| US20060024661A1 (en) * | 2003-07-30 | 2006-02-02 | The Regents Of The University Of California | Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2 |
| WO2005063749A1 (en) * | 2003-12-22 | 2005-07-14 | Sb Pharmco Puerto Rico Inc | Crf receptor antagonists and methods relating thereto |
| WO2006031322A2 (en) * | 2004-08-09 | 2006-03-23 | Research Development Foundation | Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis |
| US20060178307A1 (en) * | 2005-01-26 | 2006-08-10 | The Regents Of The University Of California | Modulation of NMDA receptor currents via orexin receptor and/or CRF receptor |
| CN103221410B (zh) | 2010-09-22 | 2017-09-15 | 艾尼纳制药公司 | Gpr119受体调节剂和对与其相关的障碍的治疗 |
| CA3002540C (en) | 2015-01-06 | 2023-11-07 | Arena Pharmaceuticals, Inc. | Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor |
| JP6838744B2 (ja) | 2015-06-22 | 2021-03-03 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩 |
| CN110520124A (zh) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | 用于治疗原发性胆汁性胆管炎的化合物和方法 |
| JP7397011B2 (ja) | 2018-06-06 | 2023-12-12 | アリーナ ファーマシューティカルズ， インコーポレイテッド | Ｓ１ｐ１受容体に関連する状態を治療する方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1129091T3 (da) * | 1998-11-12 | 2002-11-04 | Neurocrine Biosciences Inc | Antagonister for CRF-receptorer og fremgangsmåder med relation dertil |
| CA2349904A1 (en) | 1998-11-12 | 2000-05-18 | Neurocrine Biosciences, Inc. | Crf receptor antagonists and methods relating thereto |
-
2001
- 2001-11-02 CA CA002427656A patent/CA2427656A1/en not_active Abandoned
- 2001-11-02 EP EP01987366A patent/EP1341793B1/en not_active Expired - Lifetime
- 2001-11-02 JP JP2002543490A patent/JP2004529075A/ja active Pending
- 2001-11-02 KR KR10-2003-7006155A patent/KR20030060927A/ko not_active Withdrawn
- 2001-11-02 ES ES01987366T patent/ES2279835T3/es not_active Expired - Lifetime
- 2001-11-02 DE DE60126134T patent/DE60126134T2/de not_active Expired - Fee Related
- 2001-11-02 US US10/016,694 patent/US6747034B2/en not_active Expired - Fee Related
- 2001-11-02 AU AU2002239589A patent/AU2002239589B2/en not_active Ceased
- 2001-11-02 WO PCT/US2001/047919 patent/WO2002040480A2/en not_active Ceased
- 2001-11-02 AU AU3958902A patent/AU3958902A/xx active Pending
- 2001-11-02 MX MXPA03003714A patent/MXPA03003714A/es active IP Right Grant
-
2003
- 2003-05-02 NO NO20031997A patent/NO20031997D0/no not_active Application Discontinuation
-
2004
- 2004-04-22 US US10/830,416 patent/US20040266799A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002239589B2 (en) | 2005-04-21 |
| ES2279835T3 (es) | 2007-09-01 |
| WO2002040480A3 (en) | 2003-05-15 |
| EP1341793B1 (en) | 2007-01-17 |
| NO20031997D0 (no) | 2003-05-02 |
| US6747034B2 (en) | 2004-06-08 |
| US20020151557A1 (en) | 2002-10-17 |
| CA2427656A1 (en) | 2002-05-23 |
| EP1341793A2 (en) | 2003-09-10 |
| DE60126134D1 (de) | 2007-03-08 |
| WO2002040480A2 (en) | 2002-05-23 |
| DE60126134T2 (de) | 2007-10-18 |
| AU3958902A (en) | 2002-05-27 |
| US20040266799A1 (en) | 2004-12-30 |
| MXPA03003714A (es) | 2004-05-04 |
| JP2004529075A (ja) | 2004-09-24 |
| KR20030060927A (ko) | 2003-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20021361D0 (no) | Fremgangsmåte for rask og omfattende formasjonsevaluering | |
| IS7040A (is) | 5-HT viðtakabindlar og notkun þeirra | |
| DK1202941T3 (da) | Gipssammensætninger og beslægtede fremgangsmåder | |
| DK1122244T3 (da) | Uracilforbindelser og anvendelse deraf | |
| NO20013393D0 (no) | Brönnsementeringsfremgangsmåter og sammensetninger | |
| NO20024874L (no) | Benzoamidpiperidin-inneholdende forbindelser og beslektede forbindelser | |
| NO20024355L (no) | Nukleosidforbindelser og anvendelser derav | |
| NO20014553D0 (no) | Brönnplanlegging og konstruksjon | |
| DK2325317T3 (da) | Receptornukleinsyrer og polypeptidr | |
| NO20021449D0 (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav | |
| DK1251848T3 (da) | Gyraseinhibitorer og anvendelse deraf | |
| NO20032668L (no) | Gyraseinhibitorer og anvendelser derav | |
| DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
| IS6802A (is) | 3-arýlindólafleiður og notkun þeirra sem CB2 viðtakagerandefni | |
| NO20030471D0 (no) | Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor | |
| DK1322597T3 (da) | Fremgangsmåde og intermediære | |
| NO20032542L (no) | Dempede anti-CD28-antistoffer og anvendelse derav | |
| NO20031997D0 (no) | CRF-reseptor-antagonist og metoder relatert dertil | |
| NO20030228D0 (no) | Antennestruktur og assosiert fremgangsmåte | |
| IS8526A (is) | CRF viðtakamótlyf og aðferðir tengdar þeim | |
| DK1334106T3 (da) | Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf | |
| NO20030822L (no) | Nye forbindelser og fremgangsmåter | |
| IS7438A (is) | Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi | |
| NO20042500L (no) | Chemokin-reseptorantagonister og metoder for anvendelse derav | |
| NO20032821D0 (no) | Sea-trosy og beslektede fremgangsmåter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |